MLH1 and neoplasm: Aberrant promoter hypermethylation is a hallmark of CRC that has a pivotal role in defining tumour subtypes; somatic methylation of the MLH1 promoter causes the majority of sporadic CRC tumours with microsatellite instability (MSI), and widespread CpG island methylation defines the CpG island methylator phenotype (CIMP).